Conversion therapies for initially unresectable hepatocellular Carcinoma

被引：0
|
作者：
Fritsch, J. [1 ]
Ardelt, M. [1 ]
Settmacher, U. [1 ]
机构：
[1] Univ Klinikum Jena, Klin Allgemein Viszeral & Gefasschirurg, Klinikum 1, D-07747 Jena, Germany
来源：
CHIRURGIE | 2025年 / 96卷 / 01期
关键词：
D O I：
10.1007/s00104-024-02207-6
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [31] Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
    Hai-Tao Zhao
    Jian-Qiang Cai
    World Journal of Gastroenterology, 2021, 27 (47) : 8069 - 8080
  • [32] Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
    Zhao, Hai-Tao
    Cai, Jian-Qiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (47) : 8069 - 8080
  • [33] Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials - II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma
    Schwartz, JD
    Beutler, AS
    ANTI-CANCER DRUGS, 2004, 15 (05) : 439 - 452
  • [34] The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy
    Yoshimoto, Toshiaki
    Imura, Satoru
    Morine, Yuji
    Ikemoto, Tetsuya
    Arakawa, Yusuke
    Iwahashi, Shuichi
    Saito, Yu
    Takasu, Chie
    Ishikawa, Daichi
    Teraoku, Hiroki
    Bando, Yoshimi
    Shimada, Mitsuo
    ANTICANCER RESEARCH, 2018, 38 (01) : 501 - 507
  • [35] Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib Three case reports
    Tomonari, Tetsu
    Sato, Yasushi
    Tanaka, Hironori
    Tanaka, Takahiro
    Taniguchi, Tatsuya
    Sogabe, Masahiro
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Saito, Yu
    Imura, Satoru
    Bando, Yoshimi
    Shimada, Mitsuo
    Takayama, Tetsuji
    MEDICINE, 2020, 99 (42) : E22782
  • [36] Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study
    Yi, Yong
    Sun, Bao-Ye
    Weng, Jia-Lei
    Zhou, Cheng
    Zhou, Chen-Hao
    Cai, Ming-Hao
    Zhang, Jing-Yun
    Gao, Hong
    Sun, Jian
    Zhou, Jian
    Fan, Jia
    Ren, Ning
    Qiu, Shuang-Jian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Salvage Surgery for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Downstaged by Hepatic Arterial Infusion Chemotherapy
    Goto, Yuichi
    Hisaka, Toru
    Sakai, Hisamune
    Takagi, Katsuaki
    Fukutomi, Shogo
    Akagi, Yoshito
    Okuda, Koji
    ANTICANCER RESEARCH, 2020, 40 (08) : 4773 - 4777
  • [38] Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma
    Chen, Haoqi
    Wang, Xiaowen
    Zhu, Wenfeng
    Li, Yang
    Yu, Zhenyu
    Li, Hua
    Yang, Yang
    Zhu, Shuguang
    Chen, Xiaolong
    Wang, Genshu
    BMC SURGERY, 2022, 22 (01)
  • [39] Downstaging radiotherapy and surgical transformation for initially unresectable or borderline resectable hepatocellular carcinoma: A phase II study
    Su, Ting-Shi
    Gong, Wen-Feng
    Zhao, Chang
    Liang, Shi-Xiong
    Li, Le-Qun
    Xiang, Bang-De
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [40] Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma
    Haoqi Chen
    Xiaowen Wang
    Wenfeng Zhu
    Yang Li
    Zhenyu Yu
    Hua Li
    Yang Yang
    Shuguang Zhu
    Xiaolong Chen
    Genshu Wang
    BMC Surgery, 22
12345